HEALTH● LOWSep 2 · Sep 2, 2026, 9:15 PM
INVENTIVA : Inventiva Announces Last Patient Visit in NATiV3 Phase 3 Clinical Trial of Lanifibranor in MASH
finanznachrichten.de · Germany · western europe
Inventiva announced the final patient visit in its Phase 3 clinical trial for Lanifibranor, a key development in its research for MASH treatment.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More from Germany
CONFLICT13h agoGermany has stood by Ukraine throughout Russia’s invasion. A trial over the Nord Stream explosions could put Berlin’s unconditional support to the test.Meduza [en]CONFLICT14h agoNord Stream trial opens in Germany, defense seeks dismissalDW News [en]POLITICS17h agoGermany's far-right AfD forges a pro-Russia alliance with the BSWDW News [en]DISASTER18h ago3 Indians killed in Germany building fire, murder suspect heldindianexpress · india
More in Health
HEALTH23m agoPope Leo XIV has 'good night' in hospital after lung surgery, Vatican saysEuroNews [en]HEALTH41m agoWHO Urges Action On Lead Poisoning DangersChannels TVHEALTH44m agoPublic warned of poisonous mushrooms resembling edible varietiesJapan TodayHEALTH46m ago'Spain's hallmark in Vatican': The Spanish medical science behind Pope Francis' lung operationEuroNews [en]